Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-21

FDA Approved: RAMELTEON — Original Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a generic ramelteon product from Granules Pharmaceuticals Inc. for treatment of insomnia, expanding access to this sleep-onset medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

ORIG AP for RAMELTEON (RAMELTEON)